4.2 Article

Fancd2 and p21 function independently in maintaining the size of hematopoietic stem and progenitor cell pool in mice

期刊

STEM CELL RESEARCH
卷 11, 期 2, 页码 687-692

出版社

ELSEVIER SCIENCE BV
DOI: 10.1016/j.scr.2013.04.010

关键词

-

资金

  1. NIH [2 P01 HL048546-16A1]
  2. NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL048546] Funding Source: NIH RePORTER
  3. NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM071338] Funding Source: NIH RePORTER

向作者/读者索取更多资源

Fanconi anemia patients suffer from progressive bone marrow failure. An overactive p53 response to DNA damage contributes to the progressive elimination of Fanconi anemia hematopoietic stem and progenitor cells (HSPC), and hence presents a potential target for therapeutic intervention. To investigate whether the cell cycle regulatory protein p21 is the primary mediator of the p53-dependent stem cell toss, p21/Fancd2 double-knockout mice were generated. Surprisingly double mutant mice displayed even more severe loss of HSPCs than Fancd2(-/-) single mutants. p21 deletion did not rescue the abnormal cell cycle profile and had no impact on the long-term repopulating potential of Fancd2(-/-) bone marrow cells. Collectively, our data indicate that p21 has an indispensable role in maintaining a normal HSPC pool and suggest that other p53-targeted factors, not p21, mediate the progressive elimination of HSPC in Fanconi anemia. (C) 2013 Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Biotechnology & Applied Microbiology

Induced Liver Regeneration Enhances CRISPR/Cas9-Mediated Gene Repair in Tyrosinemia Type 1

Qing-Shuo Zhang, Amita Tiyaboonchai, Sean Nygaard, Kevin Baradar, Angela Major, Niveditha Balaji, Markus Grompe

Summary: Enhancing the efficiency of gene repair by homologous recombination in the liver can be achieved through CRISP/Cas9 incision near the mutation site. Interventions to further improve in vivo hepatocyte gene repair include inducing cell division with thyroid hormone T3 in neonatal mice and investigating the importance of the Fanconi anemia DNA repair pathway in hepatocyte gene repair.

HUMAN GENE THERAPY (2021)

Article Cell & Tissue Engineering

MYC Promotes Bone Marrow Stem Cell Dysfunction in Fanconi Anemia

Alfredo Rodriguez, Kaiyang Zhang, Anniina Farkkila, Jessica Filiatrault, Chunyu Yang, Martha Velazquez, Elissa Furutani, Devorah C. Goldman, Benilde Garcia de Teresa, Gilda Garza-Mayen, Kelsey McQueen, Larissa A. Sambel, Bertha Molina, Leda Torres, Marisol Gonzalez, Eduardo Vadillo, Rosana Pelayo, William H. Fleming, Markus Grompe, Akiko Shimamura, Sampsa Hautaniemi, Joel Greenberger, Sara Frias, Kalindi Parmar, Alan D. D'Andrea

Summary: The overexpression of MYC in Fanconi anemia (FA) patients leads to dysfunction of hematopoietic stem and progenitor cells (HSPCs) and increased DNA damage. MYC-high HSPCs exhibit a significant downregulation of cell adhesion genes, facilitating the egress of HSPCs from bone marrow to peripheral blood.

CELL STEM CELL (2021)

Article Biotechnology & Applied Microbiology

Liver Injury Increases the Incidence of HCC following AAV Gene Therapy in Mice

Dhwanil A. Dalwadi, Laura Torrens, Jordi Abril-Fornaguera, Roser Pinyol, Catherine Willoughby, Jeffrey Posey, Josep M. Llovet, Christian Lanciault, David W. Russell, Markus Grompe, Willscott E. Naugler

Summary: Integration of adeno-associated virus (AAV) into host genomes can lead to hepatocellular carcinoma (HCC), especially when it occurs in oncogenic hotspots. Research has shown that mice exposed to rAAV gene therapy in the context of non-alcoholic fatty liver disease (NAFLD) are more likely to develop HCC, highlighting the potential risk factors associated with rAAV-induced oncogenesis.

MOLECULAR THERAPY (2021)

Article Hematology

Inhibition of TGFβ1 and TGFβ3 promotes hematopoiesis in Fanconi anemia

Alfredo Rodriguez, Chunyu Yang, Elissa Furutani, Benilde Garcia de Teresa, Martha Velazquez, Jessica Filiatrault, Larissa A. Sambel, Tin Phan, Patricia Flores-Guzman, Silvia Sanchez, Angelica Monsivais Orozco, Hector Mayani, Ozge V. Bolukbasi, Anniina Farkkila, Michael Epperly, Joel Greenberger, Akiko Shimamura, Sara Frias, Markus Grompe, Kalindi Parmar, Alan D. D'Andrea

Summary: Fanconi anemia (FA) is a chromosome instability syndrome with congenital abnormalities, cancer predisposition, and bone marrow failure (BMF). AVID200, a TGF beta 1- and TGF beta 3-specific inhibitor, shows promising effects on FA hematopoiesis, particularly in patients progressing to severe aplastic anemia or myelodysplastic syndrome (MDS). AVID200 downregulates NHEJ-related genes and reduces DNA damage in primary FA HSPCs, indicating its potential as a therapeutic approach for improving BMF in FA.

EXPERIMENTAL HEMATOLOGY (2021)

Article Gastroenterology & Hepatology

Dynamic Transcriptional and Epigenetic Changes Drive Cellular Plasticity in the Liver

Allyson J. Merrell, Tao Peng, Jinyang Li, Kathryn Sun, Bin Li, Takeshi Katsuda, Markus Grompe, Kai Tan, Ben Z. Stanger

Summary: Hepatocytes undergo extensive chromatin and transcriptional changes during biliary reprogramming, resulting in altered gene expression profiles including robust induction of biliary genes and weaker repression of hepatocyte genes. Single-cell analysis revealed that Smad4 mutation can significantly increase reprogramming.

HEPATOLOGY (2021)

Article Biotechnology & Applied Microbiology

AAV integration in human hepatocytes

Dhwanil A. Dalwadi, Andrea Calabria, Amita Tiyaboonchai, Jeffrey Posey, Willscott E. Naugler, Eugenio Montini, Markus Grompe

Summary: Research found a high frequency of chromosomal integrations of recombinant adeno-associated viral vectors in liver cells, with most inserted sequences heavily rearranged and accompanied by deletions of host genomic sequences at integration sites. This indicates a certain risk associated with rAAV integration.

MOLECULAR THERAPY (2021)

Article Cell Biology

Therapeutic liver repopulation by transient acetaminophen selection of gene-modified hepatocytes

Anne Vonada, Amita Tiyaboonchai, Sean Nygaard, Jeffrey Posey, Alexander Mack Peters, Shelley R. Winn, Alessio Cantore, Luigi Naldini, Cary O. Harding, Markus Grompe

Summary: The study demonstrates that therapeutic modified hepatocytes can be efficiently selected in preclinical models by using mildly hepatotoxic acetaminophen, leading to significant expansion of transgene-bearing hepatocytes and reaching therapeutic thresholds in genetic liver diseases.

SCIENCE TRANSLATIONAL MEDICINE (2021)

Article Cell & Tissue Engineering

In vitro expansion of cirrhosis derived liver epithelial cells with defined small molecules

Bin Li, Yuhan Wang, Carl Pelz, Josh Moss, Ruth Shemer, Yuval Dor, Yassmine K. Akkari, Pamela S. Canady, Willscott E. Naugler, Susan Orloff, Markus Grompe

Summary: By inhibiting specific pathways, human cirrhotic liver epithelial cells can be expanded in vitro and exhibit high proliferative capacity, with gene expression and DNA methylation analysis showing an intermediate state. Compared to their murine counterparts, human-derived liver cells have limited redifferentiation potential.

STEM CELL RESEARCH (2021)

Article Medicine, Research & Experimental

Increased CFTR expression and function from an optimized lentiviral vector for cystic fibrosis gene therapy

Laura I. Marquez Loza, Ashley L. Cooney, Qian Dong, Christoph O. Randak, Stefano Rivella, Patrick L. Sinn, Paul B. McCray

Summary: This study investigated promoter choice and CFTR codon optimization as strategies to regulate CFTR expression. The results showed that EF1 alpha produced greater currents than PGK, and identified a coCFTR sequence that conferred significantly increased functional CFTR expression. Optimal promoter and CFTR sequences advance lentiviral vectors towards CF gene therapy clinical trials.

MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2021)

Article Multidisciplinary Sciences

Generation of functional ciliated cholangiocytes from human pluripotent stem cells

Mina Ogawa, Jia-Xin Jiang, Sunny Xia, Donghe Yang, Avrilynn Ding, Onofrio Laselva, Marcela Hernandez, Changyi Cui, Yuichiro Higuchi, Hiroshi Suemizu, Craig Dorrell, Markus Grompe, Christine E. Bear, Shinichiro Ogawa

Summary: The study identifies key pathways regulating cholangiocyte maturation and successfully generates functional cholangiocytes with mature characteristics, enhancing their potential for therapeutic applications in biliary diseases.

NATURE COMMUNICATIONS (2021)

Article Biotechnology & Applied Microbiology

Development of a Beta Cell-Specific Expression Control Element for Recombinant Adeno-Associated Virus

Sunghee Chai, Youngjin Kim, Feorillo Galivo, Craig Dorrell, Leslie Wakefield, Jeffrey Posey, Amanda M. Ackermann, Klaus H. Kaestner, Matthias Hebrok, Markus Grompe

Summary: This study successfully achieved specific expression of transgenes in human beta cells by designing recombinant adeno-associated virus vectors. Specific expression was achieved by combining two regulatory elements, a promoter consisting of two INS and miRNA recognition elements. This method reduces nonspecific transgene expression and is of great significance for the treatment of diabetes.

HUMAN GENE THERAPY (2022)

Article Hematology

Metformin for treatment of cytopenias in children and young adults with Fanconi anemia

Jessica A. Pollard, Elissa Furutani, Shanshan Liu, Erica Esrick, Laurie E. Cohen, Jacob Bledsoe, Chih-Wei Liu, Kun Lu, Maria Jose Ramirez de Haro, Jordi Sumalles, Maggie Malsch, Ashley Kuniholm, Ashley Galvin, Myriam Armant, Annette S. Kim, Kaitlyn Ballotti, Lisa Moreau, Yu Zhou, Daria Babushok, Farid Boulad, Clint Carroll, Helge Hartung, Amy Hont, Taizo Nakano, Tim Olson, Sei-Gyung Sze, Alexis A. Thompson, Marcin W. Wlodarski, Xuesong Gu, Towia A. Libermann, Alan D'Andrea, Markus Grompe, Edie Weller, Akiko Shimamura

Summary: This study investigated the feasibility and tolerability of metformin treatment in patients with Fanconi anemia (FA). The results showed that metformin is safe and tolerable in nondiabetic patients with FA and may provide therapeutic benefits.

BLOOD ADVANCES (2022)

Article Gastroenterology & Hepatology

Rapid in vivo multiplexed editing (RIME) of the adult mouse liver

Takeshi Katsuda, Hector Cure, Jonathan Sussman, Kamen P. Simeonov, Christopher Krapp, Zoltan Arany, Markus Grompe, Ben Z. Stanger

Summary: This study introduces a rapid in vivo multiplexed editing (RIME) method that enables the efficient inactivation of one or more genes in the mouse liver. The method is quick, efficient, and cost-effective, making it a valuable tool for analyzing multiple genes in vivo.

HEPATOLOGY (2023)

Article Multidisciplinary Sciences

A DNA methylation atlas of normal human cell types

Netanel Loyfer, Judith Magenheim, Ayelet Peretz, Gordon Cann, Joerg Bredno, Agnes Klochendler, Ilana Fox-Fisher, Sapir Shabi-Porat, Merav Hecht, Tsuria Pelet, Joshua Moss, Zeina Drawshy, Hamed Amini, Patriss Moradi, Sudharani Nagaraju, Dvora Bauman, David Shveiky, Shay Porat, Uri Dior, Gurion Rivkin, Omer Or, Nir Hirshoren, Einat Carmon, Alon Pikarsky, Abed Khalaileh, Gideon Zamir, Ronit Grinbaum, Machmud Abu Gazala, Ido Mizrahi, Noam Shussman, Amit Korach, Ori Wald, Uzi Izhar, Eldad Erez, Vladimir Yutkin, Yaacov Samet, Devorah Rotnemer Golinkin, Kirsty L. Spalding, Henrik Druid, Peter Arner, A. M. James Shapiro, Markus Grompe, Alex Aravanis, Oliver Venn, Arash Jamshidi, Ruth Shemer, Yuval Dor, Benjamin Glaser, Tommy Kaplan

Summary: DNA methylation is an important epigenetic mark that regulates gene expression and chromatin organization. This study presents a human methylome atlas based on deep whole-genome bisulfite sequencing, providing a comprehensive analysis of 39 cell types from 205 healthy tissue samples. The atlas reveals tissue-specific methylation patterns and potential biomarkers for liquid biopsies.

NATURE (2023)

Article Multidisciplinary Sciences

Self-cleaving guide RNAs enable pharmacological selection of precise gene editing events in vivo

Amita Tiyaboonchai, Anne Vonada, Jeffrey Posey, Carl Pelz, Leslie Wakefield, Markus Grompe

Summary: This study uses self-cleaving gRNAs to create drug-selectable gene editing events in specific hepatocyte loci, resulting in expanded gene-edited cells and therapeutic levels of gene expression.

NATURE COMMUNICATIONS (2022)

暂无数据